Irbinitinib NEW
Price | Get Latest Price |
Package | 1KG |
Min. Order: | 1KG |
Supply Ability: | 1000KGS |
Update Time: | 2024-08-15 |
Product Details
Product Name: Irbinitinib | CAS No.: 937263-43-9 |
Min. Order: 1KG | Purity: 98% |
Supply Ability: 1000KGS | Release date: 2024/08/15 |
Email: sales@anbuchem.com
Whatsapp:+8618638608485
24 hours online, Welcom to inquiry.
Irbinitinib Basic information
Product Name: Irbinitinib
Synonyms: ONT-380);N4-(4-([1;4,6-QuinazolinediaMine, N6-(4,5-dihydro-4,4-diMethyl-2-oxazolyl)-N4-[3-Methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-;N6-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4,6-quinazolinediamine;Irbinitinib;Irbinitinib(ARRY380);Irbinitinib (ARRY-380,Tucatinib,ONT 380);IRBINITINIB (ARRY-380; ONT-380)
CAS: 937263-43-9
MF: C26H24N8O2
MW: 480.52
EINECS: 200-001-8
Product Categories: Inhibitors;API
Mol File: 937263-43-9.mol
Irbinitinib Structure
Irbinitinib Chemical Properties
density 1.41±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMF:1.0(Max Conc. mg/mL);2.08(Max Conc. mM)
DMSO:49.0(Max Conc. mg/mL);101.97(Max Conc. mM)
DMSO:PBS (pH 7.2) (1:2):0.33(Max Conc. mg/mL);0.69(Max Conc. mM)
form A crystalline solid
pka 6.61±0.70(Predicted)
InChIKey SDEAXTCZPQIFQM-UHFFFAOYSA-N
SMILES N1=C2C(C=C(NC3=NC(C)(C)CO3)C=C2)=C(NC2=CC=C(OC3C=CN4N=CN=C4C=3)C(C)=C2)N=C1
Safety Information
MSDS Information
Irbinitinib Usage And Synthesis
Description Irbinitinib is also known as ARRY-380 or Tucatinib. ARRY-380 is an orally inhibitor of human epidermal growth factor receptor tyrosine kinase ErbB-2 (also called HER2) with potential antineoplastic activity. It selectively binds to and inhibits the phosphorylation of ErbB-2, which may prevent the activation of ErbB-2 signal transduction pathways, resulting in growth inhibition and death of ErbB-2-expressing tumor cells. ErbB-2 is overexpressed in a variety of cancers and plays an important role in cellular proliferation and differentiation. Therefore, ARRY-380 may be an alternative treatmentmethod for the treatment of HER2+ cancers.
Uses N6-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4,6-quinazolinediamine is a novel?diarylamine ErbB inhibitor.
References Lee, P., et al. "In Vivo Activity of ARRY-380, a Potent, Small Molecule Inhibitor of ErbB2 in Combination with Trastuzumab, Docetaxel or Bevacizumab." Cancer Research 69.24 Supplement(2009):5104-5104.
Moulder, S. L., et al. "Abstract A143: ARRY-380, a selective HER2 inhibitor: From drug design to clinical evaluation." Molecular Cancer Therapeutics 10.Supplement 1(2011):A143-A143.
Dinkel, Victoria, et al. "Abstract 852: ARRY-380, a potent, small molecule inhibitor of ErbB2, increases survival in intracranial ErbB2+ xenograft models in mice." Cancer Research 72.8 Supplement(2012).
Company Profile Introduction
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$30.00/2mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-19 | |
$0.00/25KG |
VIP5Y
|
Hebei Mojin Biotechnology Co., Ltd
|
2024-10-22 | |
$0.00/10mg |
VIP3Y
|
HangZhou RunYan Pharma Technology Co.,LTD.
|
2024-09-20 | |
$0.00/1KG |
VIP1Y
|
Hangzhou Hyper Chemicals Limited
|
2024-09-06 | |
$0.00/1g |
VIP1Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-07-24 | |
$0.00/1kg |
Nanjing Fred Technology Co., Ltd
|
2023-12-21 | ||
$0.00/1kg |
VIP6Y
|
Zison Pharmaceutical (Shandong) Co., Ltd.
|
2023-02-18 | |
$15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-10 | ||
$1.00/1KG |
VIP6Y
|
Career Henan Chemical Co
|
2020-01-01 | |
$15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-09 |
- Since: 2019-12-09
- Address: No 10 Yuying Road, Guancheng District, Zhengzhou 450000, China
+86-15988602810
sales@anbuchem.com